Related Experiment Video
Updated: Apr 15, 2026
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
The DNA methylation landscape of primary triple-negative breast cancer
Mattias Aine1, Deborah F Nacer1,2, Elsa Arbajian1
1Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, SE 22381, Lund, Sweden.
Abstract:
Triple-negative breast cancer (TNBC) is a clinically challenging and molecularly heterogenous breast cancer subgroup. Here, we investigate the DNA methylation landscape of TNBC. By analyzing tumor methylome profiles and accounting for the genomic context of CpG methylation, we divide TNBC into two epigenetic subtypes corresponding to a Basal and a non-Basal group, in which characteristic transcriptional patterns are correlated with DNA methylation of distal regulatory elements and epigenetic regulation of key steroid response genes and developmental transcription factors. Further subdivision of the Basal and non-Basal subtypes identifies subgroups transcending genetic and proposed TNBC mRNA subtypes, demonstrating widely differing immunological microenvironments, putative epigenetically-mediated immune evasion strategies, and a specific metabolic gene network in older patients that may be epigenetically regulated. Our study attempts to target the epigenetic backbone of TNBC, an approach that may inform future studies regarding tumor origins and the role of the microenvironment in shaping the cancer epigenome.
Insights
Triple-negative breast cancer (TNBC) can be classified into two distinct epigenetic subtypes based on DNA methylation patterns. These subtypes reveal varied immune microenvironments and potential therapeutic targets for this challenging cancer.
Area of Science:
- Epigenetics and Genomics
- Cancer Biology
- Immunology
Background:
- Triple-negative breast cancer (TNBC) is a heterogeneous and clinically difficult cancer subtype.
- Understanding the molecular underpinnings of TNBC is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the DNA methylation landscape of triple-negative breast cancer.
- To identify novel epigenetic subtypes of TNBC and their associated biological characteristics.
Main Methods:
- Analysis of tumor methylome profiles in TNBC.
- Integration of DNA methylation data with genomic context and transcriptional patterns.
- Subtyping of TNBC based on epigenetic markers.
Main Results:
- TNBC was divided into two main epigenetic subtypes (Basal and non-Basal) characterized by distinct DNA methylation and transcriptional profiles.
- Further subdivisions revealed subgroups with unique immunological microenvironments and potential immune evasion strategies.
- A specific, epigenetically regulated metabolic gene network was identified in older patients.
Conclusions:
- Epigenetic classification provides a new framework for understanding TNBC heterogeneity.
- Targeting the epigenetic landscape of TNBC may offer novel therapeutic strategies.
- Findings highlight the interplay between epigenetics, tumor microenvironment, and patient age.
Related Concept Videos
01:46Epigenetic Regulation
01:37Epigenetic Regulation
X-chromosome...